Conference Proceedings

Pooled 3-year overall survival data from phase II and phase III trials of nivolumab (NIVO) combined with ipilimumab (IPI) in advanced melanoma

Michael Postow, James Larkin, Jedd D Wolchok, Vanna Chiarion-Sileni, F Stephen Hodi, Piotr Rutkowski, Jean-Jacques Grob, Kenneth Grossmann, Dirk Schadendorf, Jason Chesney, Michael Smylie, Andrew Hill, Caroline Robert, Anna C Pavlick, John Haanen, Grant A McArthur, David McDermott, Sheena Demelo, Rafia Bhore, Rene Gonzalez

JOURNAL FOR IMMUNOTHERAPY OF CANCER | BMC | Published : 2017